Your browser doesn't support javascript.
loading
ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC.
Zhu, Ting; Xiao, Zhuoyu; Yuan, Haoyu; Tian, Hu; Chen, Taoyi; Chen, Qi; Chen, Mingkun; Yang, Jiankun; Zhou, Qizhao; Guo, Wenbin; Xue, Kangyi; Xia, Ming; Bao, Jiming; Yang, Cheng; Duan, Haifeng; Wang, Hongyi; Huang, Zhipeng; Liu, Cundong; Zhou, Junhao.
Afiliación
  • Zhu T; Department of Laboratory Medicine, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
  • Xiao Z; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Yuan H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Tian H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Chen T; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Chen Q; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Chen M; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Yang J; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Zhou Q; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Guo W; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Xue K; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Xia M; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Bao J; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Yang C; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Duan H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Wang H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Huang Z; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Liu C; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Zhou J; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Front Oncol ; 12: 929838, 2022.
Article en En | MEDLINE | ID: mdl-36059676
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza